Zacks Research Estimates Select Medical Q1 Earnings

Select Medical Holdings Co. (NYSE:SEM) – Research analysts at Zacks Research issued their Q1 2025 earnings per share estimates for Select Medical in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst Z. Masood expects that the health services provider will earn $0.43 per share for the quarter. The consensus estimate for Select Medical’s current full-year earnings is $1.17 per share. Zacks Research also issued estimates for Select Medical’s Q2 2025 earnings at $0.25 EPS, Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $1.15 EPS, Q1 2026 earnings at $0.31 EPS, Q2 2026 earnings at $0.50 EPS, Q3 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.31 EPS and FY2026 earnings at $1.44 EPS.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion.

A number of other research firms have also commented on SEM. UBS Group lowered their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 3rd. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research report on Monday, February 24th. Finally, Royal Bank of Canada lowered their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, February 24th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $27.25.

Select Medical Trading Down 1.4 %

NYSE SEM opened at $17.92 on Monday. The firm has a market capitalization of $2.31 billion, a P/E ratio of 10.86, a PEG ratio of 0.64 and a beta of 1.56. The business has a fifty day simple moving average of $18.94 and a 200 day simple moving average of $26.87. Select Medical has a 12 month low of $16.20 and a 12 month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be paid a $0.0625 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a yield of 1.40%. Select Medical’s dividend payout ratio (DPR) is presently 15.15%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SEM. Norges Bank bought a new position in Select Medical in the 4th quarter valued at $29,556,000. The Manufacturers Life Insurance Company grew its stake in shares of Select Medical by 2,552.7% during the 4th quarter. The Manufacturers Life Insurance Company now owns 1,596,414 shares of the health services provider’s stock worth $30,092,000 after acquiring an additional 1,536,234 shares during the period. Hood River Capital Management LLC grew its stake in shares of Select Medical by 404.8% during the 4th quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider’s stock worth $33,096,000 after acquiring an additional 1,407,902 shares during the period. Point72 Asset Management L.P. grew its stake in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after acquiring an additional 1,216,263 shares during the period. Finally, Invesco Ltd. grew its stake in shares of Select Medical by 48.6% during the 4th quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider’s stock worth $49,838,000 after acquiring an additional 864,852 shares during the period. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.